![]() |
|
|
Vol. 303, Issue 2, 581-591, November 2002
Department of Therapeutics and Pharmacology, Centre for
Cardiovascular and Genetics Research, School of Medicine, The Queen's
University of Belfast, United Kingdom (D.B., A.R.A., E.J.K., B.J.McD.);
and Division of Gastrointestinal Hormones, Department of Surgery,
University of Cincinnati Medical Center, Cincinnati, Ohio (A.B.)
To determine whether neuropeptide Y (NPY)-related mechanisms become
activated with progression of cardiac hypertrophy in vivo, protein mass
and de novo protein synthesis (incorporation of [14C]Phe,
0.1 µCi ml
1) were assessed in cardiomyocytes, obtained
from spontaneously hypertensive rats (SHRs) and normotensive Wistar
Kyoto rats (8, 12, 16, 20, and 24 weeks of age), and cultured
for 24 h. NPY (10
8 M) increased protein mass of
cardiomyocytes from 16-week-old SHRs by 9.2 ± 2.1%
(n = 8, P < 0.05). De novo
protein synthesis was increased maximally in SHRs at 12, 16, and 20 weeks (P < 0.05, n = 8) in
response to NPY by 12.6 ± 2.1% (10
6 M), 20.1 ± 4.2% (10
8 M), and 9.4 ± 1.8%
(10
7 M), respectively. Peptide YY3-36,
(PYY3-36), which displays selectivity for NPY
Y2 and NPY Y5 receptors, and the NPY
Y5-selective agonist
[D-Trp34]-NPY increased de novo
protein synthesis maximally by 16.2 ± 5.1% (10
7 M;
n = 4, P < 0.05) and 17.8 ± 5.2% (10
6 M; n = 7, P < 0.05), respectively, in SHRs at 16 weeks,
whereas [Leu31Pro34]-NPY
(
10
6 M), which displays some activity at NPY
Y1 and NPY Y4 receptors, did not. The NPY
Y1-selective antagonist BVD-42 (2 × 10
7
M) and the NPY Y2-selective antagonist BIIE0246 (2 × 10
7 M) did not attenuate responses to NPY
(10
7 M) and PPY3-36 (10
7 M).
These data indicate that hypertrophic responsiveness to NPY, mediated
via NPY Y5 receptors, is induced transiently in SHR
cardiomyocytes subsequent to onset of cardiomyocyte hypertrophy in
response to pressure overload.
This article has been cited by other articles:
![]() |
A. R. Allen, E. J. Kelso, D. Bell, Y. Zhao, P. Dickson, and B. J. McDermott Modulation of Contractile Function through Neuropeptide Y Receptors during Development of Cardiomyocyte Hypertrophy J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1286 - 1296. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Protas, J. Qu, and R. B. Robinson Neuropeptide Y: Neurotransmitter or Trophic Factor in the Heart? Physiology, October 1, 2003; 18(5): 181 - 185. [Abstract] [Full Text] [PDF] |
||||